Early Palliative Care in Patients with Glioblastoma: Co-Design of an Integrated Care Pathway.

IF 2.7 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Esmée K J van der Poort, Monique C M Baas-Thijssen, Marleen Oomes, Maaike J Vos, Robin M Pieterman, Martin J B Taphoorn, Inge de Vries, Carla Juffermans, Eline F de Vries, Yvette M van der Linden, Johan A F Koekkoek
{"title":"Early Palliative Care in Patients with Glioblastoma: Co-Design of an Integrated Care Pathway.","authors":"Esmée K J van der Poort, Monique C M Baas-Thijssen, Marleen Oomes, Maaike J Vos, Robin M Pieterman, Martin J B Taphoorn, Inge de Vries, Carla Juffermans, Eline F de Vries, Yvette M van der Linden, Johan A F Koekkoek","doi":"10.3390/healthcare13182378","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Glioblastoma is an incurable form of brain cancer with a median overall survival of 1.5 years. Despite its progressive nature and high symptom burden, palliative care is not consistently integrated in routine glioblastoma care. Early integration of palliative care better addresses the needs of patients and caregivers, improves quality of life, and reduces inappropriate care in the end-of-life phase. This study aims to design an integrated care pathway to support the early integration of palliative care for patients with glioblastoma. <b>Methods:</b> We used a design thinking approach, engaging stakeholders from neuro-oncology, specialist palliative care, primary care, district nursing, healthcare administration, health insurance, health economics, and patient advocacy. The process consisted of thirteen informal interviews (with healthcare professionals, patients, and caregivers), six expert meetings, and two workshops. <b>Results:</b> First, we mapped existing routine glioblastoma care and identified perceived barriers to early palliative care integration, including variations in advance care planning (ACP) timing, clinicians' hesitation, unclear referral criteria to specialist palliative care, suboptimal care coordination, and limited experience with glioblastoma in the primary care setting. Second, iterative prototyping led to the development of a care pathway with key components: initiation of ACP by the lead clinician within six weeks of diagnosis, integrated multidisciplinary team meetings for complex cases, ongoing coordination, clear referral triggers for specialist palliative care, and structured caregiver care. <b>Conclusions:</b> The co-designed pathway provides a feasible model for integrating early palliative care into routine care for patients with glioblastoma. Future steps include implementation and evaluation of the care pathway and development of a payment model.</p>","PeriodicalId":12977,"journal":{"name":"Healthcare","volume":"13 18","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12469345/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Healthcare","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/healthcare13182378","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Glioblastoma is an incurable form of brain cancer with a median overall survival of 1.5 years. Despite its progressive nature and high symptom burden, palliative care is not consistently integrated in routine glioblastoma care. Early integration of palliative care better addresses the needs of patients and caregivers, improves quality of life, and reduces inappropriate care in the end-of-life phase. This study aims to design an integrated care pathway to support the early integration of palliative care for patients with glioblastoma. Methods: We used a design thinking approach, engaging stakeholders from neuro-oncology, specialist palliative care, primary care, district nursing, healthcare administration, health insurance, health economics, and patient advocacy. The process consisted of thirteen informal interviews (with healthcare professionals, patients, and caregivers), six expert meetings, and two workshops. Results: First, we mapped existing routine glioblastoma care and identified perceived barriers to early palliative care integration, including variations in advance care planning (ACP) timing, clinicians' hesitation, unclear referral criteria to specialist palliative care, suboptimal care coordination, and limited experience with glioblastoma in the primary care setting. Second, iterative prototyping led to the development of a care pathway with key components: initiation of ACP by the lead clinician within six weeks of diagnosis, integrated multidisciplinary team meetings for complex cases, ongoing coordination, clear referral triggers for specialist palliative care, and structured caregiver care. Conclusions: The co-designed pathway provides a feasible model for integrating early palliative care into routine care for patients with glioblastoma. Future steps include implementation and evaluation of the care pathway and development of a payment model.

Abstract Image

Abstract Image

胶质母细胞瘤患者的早期姑息治疗:综合护理途径的共同设计。
背景:胶质母细胞瘤是一种无法治愈的脑癌,中位总生存期为1.5年。尽管它的进行性和高症状负担,姑息治疗不始终纳入常规胶质母细胞瘤治疗。早期整合姑息治疗可以更好地满足患者和护理人员的需求,提高生活质量,并减少生命末期的不当护理。本研究旨在设计一个综合护理途径,以支持胶质母细胞瘤患者姑息治疗的早期整合。方法:我们采用设计思维方法,让来自神经肿瘤学、专科姑息治疗、初级保健、地区护理、医疗管理、健康保险、卫生经济学和患者倡导的利益相关者参与进来。该过程包括13次非正式访谈(与医疗保健专业人员、患者和护理人员)、6次专家会议和2次研讨会。结果:首先,我们绘制了现有的常规胶质母细胞瘤护理,并确定了早期姑息治疗整合的感知障碍,包括提前护理计划(ACP)时间的变化、临床医生的犹豫、转诊到专科姑息治疗的标准不明确、护理协调不理想以及初级保健环境中胶质母细胞瘤的经验有限。其次,迭代原型导致了一个关键组成部分的护理路径的发展:由首席临床医生在诊断后六周内启动ACP,针对复杂病例的综合多学科团队会议,持续的协调,明确的专科姑息治疗转诊触发器,以及结构化的护理人员护理。结论:共同设计的路径为将早期姑息治疗纳入胶质母细胞瘤患者的常规护理提供了一种可行的模式。未来的步骤包括实施和评估护理途径以及制定支付模式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Healthcare
Healthcare Medicine-Health Policy
CiteScore
3.50
自引率
7.10%
发文量
0
审稿时长
47 days
期刊介绍: Healthcare (ISSN 2227-9032) is an international, peer-reviewed, open access journal (free for readers), which publishes original theoretical and empirical work in the interdisciplinary area of all aspects of medicine and health care research. Healthcare publishes Original Research Articles, Reviews, Case Reports, Research Notes and Short Communications. We encourage researchers to publish their experimental and theoretical results in as much detail as possible. For theoretical papers, full details of proofs must be provided so that the results can be checked; for experimental papers, full experimental details must be provided so that the results can be reproduced. Additionally, electronic files or software regarding the full details of the calculations, experimental procedure, etc., can be deposited along with the publication as “Supplementary Material”.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信